Success Metrics

Completion Rate
0%(0/1)
Active Trials
2(50%)
Terminated
1(25%)

Phase Distribution

Ph not_applicable
2
50%
Ph phase_3
1
25%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution3 total trials
Phase 3Large-scale testing
1(33.3%)
N/ANon-phased studies
2(66.7%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

0.0%

0 of 2 finished

Non-Completion Rate

100.0%

2 ended early

Currently Active

2

trials recruiting

Total Trials

4

all time

Status Distribution
Active(2)
Terminated(2)

Detailed Status

Recruiting1
Active, not recruiting1
Terminated1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
2
Success Rate
0.0%
Most Advanced
Phase 3

Trials by Phase

Phase 31 (33.3%)
N/A2 (66.7%)

Trials by Status

recruiting125%
active_not_recruiting125%
terminated125%
withdrawn125%

Recent Activity

2 active trials
Showing 4 of 4
recruitingnot_applicable

Comparison Between Liquid-Based Cytology And Molecular Screening For Detecting Precursor Lesions and Cervical Cancer

NCT07480902
withdrawnnot_applicable

Comparison Of Cytology And Molecular Screening For Detecting Cervical Reactive Cellular Changes In General Population

NCT07211204
active_not_recruitingphase_3

The Study for the "Cervical Cancer Screening and Treatment Algorithms Study Using HPV Testing in Africa"

NCT04794660
terminated

Intended Use Study of the BD SurePath Plus™ Pap

NCT01234480

Clinical Trials (4)

Showing 4 of 4 trials
NCT07480902Not Applicable

Comparison Between Liquid-Based Cytology And Molecular Screening For Detecting Precursor Lesions and Cervical Cancer

Recruiting
NCT07211204Not Applicable

Comparison Of Cytology And Molecular Screening For Detecting Cervical Reactive Cellular Changes In General Population

Withdrawn
NCT04794660Phase 3

The Study for the "Cervical Cancer Screening and Treatment Algorithms Study Using HPV Testing in Africa"

Active Not Recruiting
NCT01234480

Intended Use Study of the BD SurePath Plus™ Pap

Terminated

All 4 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
4